About the role
Greenbrook Mental Wellness Centers, a subsidiary of Neuronetics, Inc.,
is seeking a
Board Certified or Board Eligible Psychiatrist
to provide onsite oversight of Transcranial Magnetic Stimulation (TMS) treatments and support the growth of our Spravato® (esketamine) program when we open our newest location in Round Rock, TX.
Why Join Us?
Flexible schedule
Flexible Part-Time Schedule (1099)
No nights, weekends, or on-call responsibilities
Competitive compensation
TMS certification and training provided
Opportunity to expand your expertise in interventional psychiatry
Collaborative clinical and operational support team
Make a meaningful impact on patients with treatment-resistant depression and other mental health disorders
Qualifications
MD or DO
Board Certified or Board Eligible
Active Texas medical license (or ability to obtain)
DEA registration (or ability to obtain)
About Greenbrook
Greenbrook Mental Wellness Centers, a subsidiary of
Neuronetics, Inc.
, is a leading provider of TMS and Spravato® therapies, delivering innovative, evidence-based treatments for depression, OCD, and other mental health conditions. Through a nationwide network of treatment centers, Greenbrook is helping patients find relief when traditional treatments have not been successful.
Join us in transforming mental health care and improving lives.
Learn More
Provider Information:
Greenbrook for Providers | TMS Therapy & Esketamine
Patient Stories:
Patient Stories | Greenbrook
Our Why:
https://youtu.be/yrr-wlFftT0
GBSP25
About Us
Neuronetics, Inc. is a leading mental healthcare company, now encompassing Greenbrook TMS as a subsidiary. This strategic acquisition unites Neuronetics' innovative NeuroStar® Advanced Therapy (TMS) technology with Greenbrook's extensive network of over 95 U.S. treatment centers. The combined company provides FDA-cleared NeuroStar® TMS and Spravato® treatments for major depressive disorder (MDD) and treatment-resistant depression. With a strengthened nationwide footprint, Neuronetics is dedicated to significantly expanding patient access to these crucial therapies, integrating advanced technology with established clinical expertise to improve patient outcomes and drive growth within the mental health sector.